Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.93 - $2.15 $99,958 - $231,086
-107,482 Reduced 91.48%
10,016 $14,000
Q3 2023

Nov 13, 2023

BUY
$2.33 - $5.07 $273,770 - $595,714
117,498 New
117,498 $279,000
Q1 2022

May 13, 2022

SELL
$6.3 - $8.84 $151 - $212
-24 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$6.02 - $11.43 $144 - $274
24 New
24 $0

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $102M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.